Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells.

Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells.
复制标题

用患者特异性诱导多能干细胞建模血液病和癌症。

DOI:
10.3389/fimmu.2018.02243
复制
发表时间:
2018
影响因子:
7.3
通讯作者:
Schaniel C
Schaniel C
中科院分区:
医学2区
文献类型:
--
作者:
Kim H;Schaniel C

文献摘要

参考文献

被引文献

相似文献

诱导多能干细胞(iPSC)的出现以及基因组编辑,微生理系统,组织工程和异种移植模型的最新进展为在患者特定背景下研究血液病和癌症提供了新的机会。在这里,我们回顾了该领域的进展,并讨论了基于iPSC的恶性肿瘤建模的优势,局限性和挑战。我们还将讨论使用iPSCs及其衍生物作为药物靶点识别,药物开发和药理学反应评价的细胞来源。
The advent of induced pluripotent stem cells (iPSCs) together with recent advances in genome editing, microphysiological systems, tissue engineering and xenograft models present new opportunities for the investigation of hematological diseases and cancer in a patient-specific context. Here we review the progress in the field and discuss the advantages, limitations, and challenges of iPSC-based malignancy modeling. We will also discuss the use of iPSCs and its derivatives as cellular sources for drug target identification, drug development and evaluation of pharmacological responses.
DOI: 10.1126/scitranslmed.aah5645
发表时间: 2017-02-08
影响因子: 17.1
作者:
Doulatov S;Vo LT;Macari ER;Wahlster L;Kinney MA;Taylor AM;Barragan J;Gupta M;McGrath K;Lee HY;Humphries JM;DeVine A;Narla A;Alter BP;Beggs AH;Agarwal S;Ebert BL;Gazda HT;Lodish HF;Sieff CA;Schlaeger TM;Zon LI;Daley GQ
通讯作者: Daley GQ
DOI: 10.1038/cddis.2015.374
发表时间: 2016-02-18
影响因子: 9
作者:
Blondel S;Egesipe AL;Picardi P;Jaskowiak AL;Notarnicola M;Ragot J;Tournois J;Le Corf A;Brinon B;Poydenot P;Georges P;Navarro C;Pitrez PR;Ferreira L;Bollot G;Bauvais C;Laustriat D;Mejat A;De Sandre-Giovannoli A;Levy N;Bifulco M;Peschanski M;Nissan X
通讯作者: Nissan X
DOI: 10.1182/blood-2014-01-550525
发表时间: 2014-09-18
期刊: BLOOD
影响因子: 20.3
作者:
Connelly, Jon P.;Kwon, Erika M.;Liu, P. Paul
通讯作者: Liu, P. Paul
DOI: 10.1038/s41598-018-22749-0
发表时间: 2018-03-14
期刊: Scientific reports
影响因子: 4.6
作者:
Edington CD;Chen WLK;Geishecker E;Kassis T;Soenksen LR;Bhushan BM;Freake D;Kirschner J;Maass C;Tsamandouras N;Valdez J;Cook CD;Parent T;Snyder S;Yu J;Suter E;Shockley M;Velazquez J;Velazquez JJ;Stockdale L;Papps JP;Lee I;Vann N;Gamboa M;LaBarge ME;Zhong Z;Wang X;Boyer LA;Lauffenburger DA;Carrier RL;Communal C;Tannenbaum SR;Stokes CL;Hughes DJ;Rohatgi G;Trumper DL;Cirit M;Griffith LG
通讯作者: Griffith LG
DOI: 10.3389/fcell.2017.00111
发表时间: 2017
影响因子: 5.5
作者:
Bellissimo DC;Speck NA
通讯作者: Speck NA